Should Avastin be Added to EGFR TKI Therapy for EGFR Mutation-Positive NSCLC?

Dr. Jack West, medical oncologist, reviews evidence in favor of adding Avastin (bevacizumab) to the EGFR inhibitor Tarceva (erlotinib) for patients with lung cancer that harbors an activating EGFR mut... Author: cancergrace Added: 10/07/2015
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts